Skip to main content

EQT — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

300
Companies
$7.7B
Total invested
$150.7M
Avg. check
50
Industries
Health Care 7Biotechnology 6Life Science 5Pharmaceutical 5Artificial Intelligence (AI) 4Medical 4+44 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 300
Buena
July 2025

Buena is a property management platform for managing rentals and condos, streamlining maintenance, accounting, compliance, and reporting.

Artificial Intelligence (AI) · Berlin$58.0M Series A
Neuros Medical
July 2025

Neuros Medical develops neurostimulation therapies for patients suffering with unmet medical needs.

Health Care · Willoughby$56.0M Series D
Sifflet
June 2025

Sifflet is a data stack observability platform that delivers actionable insights to data engineers and data consumers.

Analytics · Paris$18.0M Venture - Series Unknown
Payrails
June 2025

Payrails is a payment software company that helps enterprises to take control of their payment operations and optimize performance.

Enterprise Software · Berlin$32.0M Series A
Splice Bio
June 2025

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Biotechnology · Barcelona$135.0M Series B
Mosanna Therapeutics
June 2025

Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.

Biotechnology · Redwood City$80.0M Series A
Holidu
June 2025

Holidu is a travel technology company focused on the search and booking of vacation rentals.

Search Engine · Munich$52.5M Venture - Series Unknown
Kota
May 2025

We make it extraordinarily easy to roll out and manage benefits globally.

Apps · Dublin$14.5M Series A
ViridiCO2
May 2025

ViridiCO2 delivers innovative, disruptive technology, capable of addressing the lack of mitigative Carbon Capture Utilisation technology.

B2B · LondonSeed
MarvelX
May 2025

MarvelX builds the agentic AI platform.

Artificial Intelligence (AI) · Amsterdam$6.0M Pre-Seed
Superlist
May 2025

Superlist is a collaboration tool reimagining workplace productivity through technology.

Artificial Intelligence (AI) · Berlin$561K Seed
Xilis
April 2025

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Biotechnology · Durham$19.4M Venture - Series Unknown
Avidicure
April 2025

Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.

Oegstgeest$50.0M Seed
Marvel Fusion
March 2025

Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy.

Electronics · Munich$53.9M Series B
Perfuze
March 2025

Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.

Health Care · Newcastle$23.9M Venture - Series Unknown
Ria Health
February 2025

Ria Health is an online platform providing telehealth services for alcohol use disorder.

Health Care · San Francisco$6.5M Series B
VarmX
February 2025

VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.

Manufacturing · Leiden$15.8M Venture - Series Unknown
Bluebook
February 2025

Bluebook is a self-driving system that comprehends in addition to processing transactions.

Web Development · Stockholm$3.0M Pre-Seed
Natural Cycles
January 2025

Natural Cycles is a healthcare app that uses body temperature to determine fertility status.

Apps · Stockholm$2.6M Venture - Series Unknown
Atalanta Therapeutics
January 2025

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

Biotechnology · Boston$97.0M Series B
ecoplanet
January 2025

Ecoplanet is an AI-powered energy management platform that helps industrial enterprises in their energy transition.

Artificial Intelligence (AI) · Munchen$16.7M Series A
Formo
January 2025

Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.

Biotechnology · Berlin$36.1M Debt Financing
XyloCor Therapeutics
January 2025

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

Biotechnology · King Of Prussia$67.5M Series B
Getvoila
January 2025

Germany's best chefs & restaurants, delivered nationwide. Perfect for special occasions, holidays and Christmas.

Food and Beverage · BerlinVenture - Series Unknown

Where EQT invests

Health Care7
Biotechnology6
Life Science5
Pharmaceutical5
Artificial Intelligence (AI)4
Medical4

About EQT's portfolio

How many companies has EQT invested in?▸

EQT has invested in 300 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does EQT invest in?▸

EQT's top investment sectors include Health Care, Biotechnology, Life Science, Pharmaceutical, Artificial Intelligence (AI). The firm invests across 50 different industry categories.

What is EQT's largest investment?▸

Among tracked funding rounds, Splice Bio received $135.0M in a Series B round. EQT's total known invested capital is $7.7B.

What is the average investment size for EQT?▸

EQT's average investment size is $150.7M across its portfolio of 300 companies.

What are EQT's most recent investments?▸

Recent EQT portfolio additions include Buena, Neuros Medical, Sifflet, Payrails, Splice Bio. These companies were founded in 2020 or later.

Reach the founders behind these 300 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →